Currently, cytokeratin-19 fragment 21-1 (CYFRA21-1) and carcinoembryonic antigen (CEA) are two widely researched biomarkers used together in monitoring the course of disease of NSCLC. The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.